Clinical Trial Update: An Efficacy and Safety Study of JNJ-38518168 in Adult Participants With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 efficacy and safety study of JNJ-38518168 in adults with rheumatoid arthritis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• JNJ-38518168

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED